New heart pump offers hope for advanced heart failure patients
NCT ID NCT07632586
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device called the Icoms FlowMaker, designed to help the heart pump more blood in people with severe heart failure. Ten patients who are too sick for standard treatments will receive the implant. The main goal is to see if the device is safe and works well for 30 days after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospitalier IKEM
RECRUITINGPrague, Czechia
-
Hôpital la pitié salpètrière
ACTIVE_NOT_RECRUITINGParis, 75013, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Dual-Chamber heart pump save the failing heart?
- Can a mechanical heart pump offer a lifeline for advanced heart failure?
- Heart-Kidney link under microscope in advanced heart failure study
- Could LVAD patients ditch aspirin? new trial aims to find out
- Stem cell injection during bypass surgery aims to repair damaged hearts
- Heart failure study reveals hidden danger of unintentional weight loss